End-of-day quote
Thailand S.E.
06:00:00 2024-07-10 pm EDT
|
5-day change
|
1st Jan Change
|
3.34
THB
|
0.00%
|
|
+0.60%
|
-4.02%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
880
|
1,184
|
1,496
|
3,680
|
2,607
|
2,091
|
Enterprise Value (EV)
1 |
700.9
|
1,465
|
1,705
|
3,631
|
2,565
|
1,540
|
P/E ratio
|
10.9
x
|
12.9
x
|
33.7
x
|
8.8
x
|
19.7
x
|
10.5
x
|
Yield
|
7.28%
|
8.45%
|
4.01%
|
7.37%
|
4.61%
|
8.62%
|
Capitalization / Revenue
|
1.33
x
|
1.62
x
|
1.96
x
|
1.26
x
|
2.12
x
|
1.23
x
|
EV / Revenue
|
1.06
x
|
2
x
|
2.23
x
|
1.24
x
|
2.09
x
|
0.91
x
|
EV / EBITDA
|
6.89
x
|
11.9
x
|
16.2
x
|
6.46
x
|
13.1
x
|
5.53
x
|
EV / FCF
|
-3.22
x
|
-3.33
x
|
8.91
x
|
15.5
x
|
13.1
x
|
2.81
x
|
FCF Yield
|
-31%
|
-30%
|
11.2%
|
6.47%
|
7.6%
|
35.6%
|
Price to Book
|
1.57
x
|
2.02
x
|
2.81
x
|
4.64
x
|
3.46
x
|
2.51
x
|
Nbr of stocks (in thousands)
|
600,000
|
600,000
|
600,000
|
600,000
|
600,735
|
600,735
|
Reference price
2 |
1.467
|
1.973
|
2.493
|
6.133
|
4.340
|
3.480
|
Announcement Date
|
2/21/19
|
2/20/20
|
2/24/21
|
2/23/22
|
2/22/23
|
2/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
663.7
|
733
|
765.1
|
2,927
|
1,230
|
1,695
|
EBITDA
1 |
101.8
|
123.1
|
105.3
|
562.2
|
196.4
|
278.3
|
EBIT
1 |
99.55
|
115.2
|
86.51
|
543.5
|
175.5
|
259.8
|
Operating Margin
|
15%
|
15.71%
|
11.31%
|
18.57%
|
14.27%
|
15.33%
|
Earnings before Tax (EBT)
1 |
99.49
|
108.6
|
47.58
|
526.3
|
166.7
|
251.7
|
Net income
1 |
80.6
|
91.46
|
44.4
|
420.3
|
133.4
|
201.2
|
Net margin
|
12.14%
|
12.48%
|
5.8%
|
14.36%
|
10.85%
|
11.87%
|
EPS
2 |
0.1343
|
0.1524
|
0.0740
|
0.6973
|
0.2200
|
0.3300
|
Free Cash Flow
1 |
-217.4
|
-440
|
191.4
|
234.9
|
195
|
548.8
|
FCF margin
|
-32.75%
|
-60.03%
|
25.02%
|
8.02%
|
15.86%
|
32.39%
|
FCF Conversion (EBITDA)
|
-
|
-
|
181.74%
|
41.78%
|
99.32%
|
197.21%
|
FCF Conversion (Net income)
|
-
|
-
|
431.15%
|
55.88%
|
146.16%
|
272.8%
|
Dividend per Share
2 |
0.1067
|
0.1667
|
0.1000
|
0.4519
|
0.2000
|
0.3000
|
Announcement Date
|
2/21/19
|
2/20/20
|
2/24/21
|
2/23/22
|
2/22/23
|
2/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
281
|
209
|
-
|
-
|
-
|
Net Cash position
1 |
179
|
-
|
-
|
49.3
|
42.7
|
551
|
Leverage (Debt/EBITDA)
|
-
|
2.28
x
|
1.983
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-217
|
-440
|
191
|
235
|
195
|
549
|
ROE (net income / shareholders' equity)
|
13.7%
|
12.7%
|
4.85%
|
59.1%
|
15.9%
|
23.4%
|
ROA (Net income/ Total Assets)
|
7.27%
|
5.54%
|
2.93%
|
17.7%
|
6.82%
|
11.3%
|
Assets
1 |
1,108
|
1,652
|
1,515
|
2,376
|
1,955
|
1,787
|
Book Value Per Share
2 |
0.9400
|
0.9800
|
0.8900
|
1.320
|
1.250
|
1.390
|
Cash Flow per Share
2 |
0.2000
|
0.1700
|
0.3400
|
0.5400
|
0.3900
|
1.040
|
Capex
1 |
126
|
255
|
2.79
|
1.41
|
0.28
|
8.7
|
Capex / Sales
|
18.92%
|
34.82%
|
0.37%
|
0.05%
|
0.02%
|
0.51%
|
Announcement Date
|
2/21/19
|
2/20/20
|
2/24/21
|
2/23/22
|
2/22/23
|
2/19/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.02% | 55.22M | | -14.01% | 8.22B | | +13.82% | 1.38B | | -5.84% | 1.32B | | -29.42% | 1.01B | | -32.63% | 673M | | -.--% | 618M | | +5.65% | 459M | | +1.02% | 427M | | -37.27% | 263M |
Medical Equipment Wholesale
|